Prediction of Medication Compliance - Full Text View

Prediction of Medication Compliance

This study is currently recruiting participants.
Verified by University of Minnesota, June 2007

Sponsors and Collaborators:	University of Minnesota National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Information provided by:	University of Minnesota
ClinicalTrials.gov Identifier:	NCT00148187

Purpose

The purpose of this study is to quantitate pre-transplant medication compliance, dialysis compliance, and related psychological variables, and then examine their validity as predictors of post-transplant noncompliant behaviors and clinically relevant outcomes (acute rejection, graft loss, or death).

Hypothesis: Noncompliance with pre-transplant medication or with the dialysis prescription, and specific psychological variables predict similarly noncompliant behaviors after transplantation.

Condition

Kidney Transplantation

MedlinePlus related topics:

Kidney Transplantation

U.S. FDA Resources

Study Type:	Observational
Study Design:	Natural History, Longitudinal, Convenience Sample, Prospective Study

Official Title:	Prediction of Medication Compliance Following Renal Transplantation

Further study details as provided by University of Minnesota:

Estimated Enrollment:	60
Study Start Date:	January 2003

Detailed Description:

This pilot study is intended to provide preliminary data about the feasibility of recruiting a cohort of subjects on hemodialysis and following them prospectively through the transplant procedure. The study will document patient adherence to medications and treatment, both before and after surgery. These preliminary data will permit appropriate design and power calculations for a future study assessing our ability to predict post-transplant compliance, based on pre-transplant behaviors.

Eligibility

Ages Eligible for Study:	18 Years to 70 Years
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No

Criteria

Inclusion Criteria:

Adult hemodialysis patients in renal transplant evaluation
Able to read test forms
Responsible for their own medications

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00148187

Contacts


Contact: Thomas E Nevins, MD	612-626-2922	nevin001@umn.edu

Locations


United States, Minnesota
	University of Minnesota	Recruiting
	Minneapolis, Minnesota, United States, 55455
	Contact: Thomas E Nevins, MD 612-626-2922 nevin001@umn.edu

Sponsors and Collaborators

University of Minnesota

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Investigators


Principal Investigator:	Thomas E Nevins, MD	University of Minnesota

More Information

Study ID Numbers:	0202M17442, NIH - DK13083
First Received:	September 2, 2005
Last Updated:	July 16, 2007
ClinicalTrials.gov Identifier:	NCT00148187
Health Authority:	United States: Institutional Review Board

Keywords provided by University of Minnesota:

Medication adherence

Patient compliance

Kidney transplant

Organ rejection

Allograft loss

Drug monitoring

ClinicalTrials.gov processed this record on October 14, 2008